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ABSTRACT
The purpose of this qualitative study was to explore how young adults with
perinatal HIV infection understand and experience the concept of family and to elicit
their perceptions of how “family” has helped or hindered their ability to cope with their
illness. The sample was composed of young adults currently receiving primary care from
the Johns Hopkins Intensive Primary Care Clinic (IPC) located in Baltimore, Maryland.
The IPC clinic provides comprehensive medical care and psychosocial support for over
200 children and youth with HIV infection from birth to 24 years. The majority of the
patients come from low socio-economic ethnic minority communities in Baltimore City.
All patients in the clinic were English speaking. The sample included 12 perinatally HIVinfected adolescents, ranging in age from 18 to 24. Three fourths of the participants were
female. All participants self identified as African American. All participants consented to
partake in one interviews composed of a series of open-ended questions. All interviews
were conducted in the outpatient medical clinic setting.
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CHAPTER I
INTRODUCTION
The term “family” is commonly defined as a group of persons who share the same
lineage, or as a social group, usually composed of two parents and their children. The
concept of “family of origin” refers to the family into which a person is born, whereas the
idea of “chosen family” generally refers to friends who care about each other enough to
consider them family. Chosen family can also be used to refer to adoptive relationships.
Divided or non-existent biological families may compel young adults to develop or
choose a group or groups of friends who can provide love and support. When children are
orphaned at a young age, who becomes their family?
The purpose of this study is to determine how young adults with perinatal HIV
infection understand and experience the concept of family and to elicit their perceptions
of how “family” has helped or hindered their ability to cope with their illness. HIV
transmission from mother to child during pregnancy, labor and delivery, or by breastfeeding is referred to as perinatal transmission. Perinatal HIV transmission is the most
common route of HIV infection in children and is now the source of almost all AIDS
cases in the United States. According to the Centers for Disease Control and Prevention
(CDC), since the beginning of the AIDS epidemic in the early 1980s, an estimated 8,460
children were infected perinatally. Of those, approximately 4,800 children have died.
Most of the children with AIDS are members of minority races or ethnicities.
In the United States, as well as in other geographic locations with access to
resources, the introduction of widespread HIV counseling, testing, and treatment with
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antiretroviral therapy during pregnancy resulted in a dramatic drop in the rate of perinatal
transmission. In addition, advances in antiretroviral treatment and knowledge of disease
progression, have dramatically reduced the morbidity and mortality of HIV infection in
the United States (Weiner et al. 2007). As a result, children born in the 1990s with
perinatally-acquired HIV have now survived to young adulthood. Family support is
important in nurturing their developmental and practical transition from adolescence to
independent adulthood. Unfortunately, it is estimated that the AIDS pandemic in the
United States has orphaned as many as 80,000 children and adolescents (Caldwell,
Fleming, & Oxtoby 1992).
Due to the loss of a biological parent or parents during early childhood or
adolescence, this unique cohort has experienced a variety of family constellations. Some
children were raised by members of their extended family. Other children have been
placed in the foster care system or adopted by another family. Still others were extruded
from families and have survived through “chosen families.” Little is systematically
known about the construct of family as experienced by youth with lifelong HIV infection.
This research is important because it addresses a new emerging population that must
navigate the transition from childhood to adulthood in multiple domains: educational,
vocational, personal, and healthcare related.
The Johns Hopkins Intensive Primary Care Clinic, founded in 1985, provides
comprehensive HIV medical care and psychosocial support for children and youth from
birth to 24 years in the Baltimore, Maryland area. Currently the Intensive Primary Care
(IPC) team cares for over 200 HIV-infected patients, three quarters of whom are
survivors of HIV acquired at birth from their mothers. The median age of this subgroup is
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now 18 years, with 71 already past their 18th birthday. This sub-group is diverse in
physical health status, emotional health, adherence to care and treatment, and social
support networks. The majority of these patients were orphaned, having lost at least one
parent to HIV/AIDS.
A striking but anecdotal clinical observation is that youth with fragmented or
“dysfunctional” family systems are now dying of AIDS in contrast to their more stable
peers. It is critically important for clinicians to step back from subjective assumptions and
seek to learn more systematically from the affected youth about their experiences and
perceptions of family structure and support, with the goal of improving the effectiveness
of HIV care provided. In an attempt to better understand the collective experience,
this research study will gather and analyze the unique narratives of these individuals who
have learned to navigate the world with a chronic illness.
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CHAPTER II
LITERATURE REVIEW
At the onset of the epidemic in the early 1980s, AIDS was viewed as a “death
sentence” with only 5 to 10% of individuals living for approximately three years after
diagnosis. Social stigma and the risk of transmission resulted in heightened fear among
the general public. This in turn was a catalyst for researchers to investigate possible
prevention and treatment regimens, and progression of the illness.
Because of advances in treatment and care of HIV, we are currently witnessing a
trend of youth with perinatally acquired HIV survive long enough to transition from
pediatric to adult care. Between 1996 and 1997, AIDS diagnosis of children 13 years of
age and younger declined approximately 40 %. These advances have important
ramifications for children and adolescents living with HIV. Infants born with HIV or
children infected early in life were not expected to live through their first decade as few
medications were available or accessible, and the technology was not available to
monitor the effects of treatment or disease progression (Ledlie 2001). As a result, they
may not have been raised in a manner that prepared them for adulthood and ultimately
independent living. This phenomenon has not been adequately addressed in the literature
published on this group of individuals.
Researchers have investigated a broad spectrum of topics related to children and
adolescents with HIV including: social stigma, disclosure of positive HIV status to child,
treatment compliance, medication adherence, grief and loss surrounding the death of a
parent with HIV, coping mechanisms, and the psychosocial issues that directly impact
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this cohort. Other researchers have explored why HIV/AIDS has primarily impacted
marginalized communities living in urban settings. However, little research has been
done that explores how the family unit has been impacted by this illness. Because one or
both of the child’s biological parents may have succumbed to AIDS, family
configurations vary greatly. Little is known about how youth with perinatally acquired
HIV define family, and whether their family helps or hinders their ability to cope with
their illness.
Medical providers are currently witnessing the first wave of adolescents with
perinatally acquired HIV disease transition into adulthood. Providers are confronted with
new challenges, such as treatment regimens, medication adherence, disclosure, and
permanency planning. New challenges have risen such as relationships, sexual intimacy,
college and career planning. Caregivers, who were once told that their child with HIV
would probably not live past kindergarten, were not prepared for raising an adolescent
with a chronic, sexually transmitted disease. (Ledlie, 2001). Medication regimens,
including highly active anti-retroviral therapy (HAART) are time consuming and often
cause a number of side effects. On average, an individual prescribed HAART will take
seven doses daily, which is potentially a severe burden for the patients and their
caregivers.
Many children born with HIV were reared by an elderly caregiver, usually a
grandmother or great-grandmother. It is imperative to consider how the primary
caregivers’ lives are impacted by raising a child with a highly stigmatized chronic illness.
Regardless of the family constellation, caring for a child with HIV requires a
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considerable amount of emotional energy and time devoted to maintaining medication
adherence.
In the late 1970s and1980s, as rates of divorce and remarriage skyrocketed,
researchers took an interest in the shift of a more “traditional” grandparent role from
“indulging, spoiling, enjoying” grandchildren to taking on an “unplanned parenthood”
role. Currently, grandparents across racial and ethnic divisions are called on to resume
the parenting role as more biological parents succumbed to medical illnesses (Winston,
2003). Recognizing that grandmothers care for the majority of African American children
orphaned by AIDS, Carole Winston (2003) conducted a qualitative analysis to determine
how African American grandmothers grieve the loss of their adult children, while
simultaneously parenting their orphaned grandchildren. A snowball sampling method was
used to obtain a sample of 10 African American grandmothers between 52 and 70 years
of age in the New York Metropolitan area.
Winston asserted that a predominant reason that grandmothers parented their
grandchildren stemmed from the belief that “families come first and should stay together
at all costs” (95). These grandmothers felt a responsibility to care for their grandchildren,
and adjusted their lives accordingly. The data revealed that a spiritual relationship with
God served as a significant source of strength for the participants that “enhanced their
ability to care for their grandchildren while mourning the loss of a child.” This study is
not generalizable to the entire population because of the small sample size; however, the
detailed narratives offer insight into their lives and the complexity of raising a child with
a chronic illness after experiencing the loss of their own child.
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Primary caregivers as well as family members of children born with HIV have to
consider when to disclose the child’s positive status in a developmentally appropriate
way. A number of studies have addressed the issue of disclosure of diagnosis to children
born with perinatally acquired HIV illness. Because non-adherence to the anti-retroviral
treatment HAART may lead to a form of viral mutation and proliferation, it is imperative
that the child adheres to the treatment regimens. When the child grows older, it becomes
their responsibility to adhere to the medication. Therefore, without disclosing the illness,
the importance of compliance is difficult to communicate. Because sexual exploration is
occurring at an earlier age, prolonged delay in disclosure may result in the adolescent
engaging in sexual behaviors without being counseled regarding transmission and the
practice of safe sex (Lee & Johann-Liang, 1999).
Multiple factors may prevent the parent or caregiver of an HIV positive child to
disclose their status including: social stigma, the life-threatening nature of HIV infection,
guilt over perinatal transmission, or loss of another family member or friend to AIDS.
Disclosure may elicit a number of questions such as, “How did I get it? Who gave it to
me? Why me? Am I going to die?” Responses may be difficult to articulate in a
developmentally appropriate manner, and may cause hurt or shame from the parent or
guardian (Lee & Johann-Liang, 1999). However, resisting disclosure may ultimately
cause emotional damage and impact identity development.
Instone (2000) conducted a qualitative study to investigate how school-aged
children with HIV infection adjusted to their illness and information from parents or
guardians. Participants in this study included thirteen children six to twelve years of age
with perinatally acquired HIV infection as well as their parents or guardians. Due to the
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small sample size, the study is not generalizable to the entire population of school-aged
children with perinatally acquired HIV; however, the sample was reflective of the
regional population. The data yielded that the parents withheld the children’s positive
HIV status for approximately two to eight years after diagnosis. Regardless of when the
child learned of their diagnosis, their responses to the questions “suggested severe
emotional distress, disturbed self-image, and social isolation.” Parents or guardians were
ultimately unaware of their children’s concerns (Instone, 2000). Although other
psychosocial factors impact the participants overall adjustment, it is evident that a lack of
attunement to the children’s concerns ultimately impacts their ability to understand and
cope with their illness.
As children with perinatally acquired HIV transition into adolescence, caregivers
must be prepared to address this life stage in the context of a chronic, sexually
transmitted illness. Adolescence is characterized by biological, psychological, and social
changes. In a quest to define their identity, adolescents generally rely more on their
relationships with peers rather than their family unit to obtain feedback in their quest to
define the self and establish autonomy. However, disclosure of their positive status to
peers is a complex process. Many adolescents fear that disclosing their status to a friend
or partner will ultimately lead to rejection. Anxiety related to disclosure of their positive
status may effect many of their friendships and intimate partner relationships in the
future. Caregivers and clinicians must be attuned to these additional factors that result in
an increased level of anxiety or distress.
This stage of social development poses additional obstacles for an adolescent with
a chronic illness as they may be more reliant upon family members or caregivers for
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transportation to medical appointments or to the pharmacy to pick up medication. With
respect to their medication regimen and treatment plan, adolescents may decide that they
want a “break” and ultimately discontinue anti-retroviral treatment. The most common
reasons that adolescents report for stopping their medication regimens include: side
effects (diarrhea, nausea, vomiting, fatigue, weakness, fever, and chills), inconvenience
of taking medication multiple times a day, HIV stigma and disclosure, lack of family
support, and a reminder that they are HIV infected when they take them (Belzer et al.,
1998). As children they may have taken their medication because grandma said to. Now
they may consider not to take their medication just because grandma said to (Ledlie,
2001). Notably individuals with HIV that discontinue use of anti-retroviral treatment (or
take it inconsistently) ultimately run the risk of developing immunity to the treatment
therapy. Subsequently, effective treatment options will decrease. Because of this risk,
clinicians working with this population recognize the significance of having a support
system in place.
Davey et. al (2009) conducted a research study to determine if it is beneficial for
clinicians to use a family support tool to identify perceived levels of family support for
individual clients before and after disclosure of the HIV diagnosis to their families. In
addition, they considered what the long-term benefits may be from using this clinical tool
to inform clinical and medical treatment for youth coping with HIV. The sample included
50 newly diagnosed HIV positive ethnic, minority youth. According to the clinician rated
five point family support tool ranging from one (very supportive) to 5 (very
unsupportive), participants had a mean score of 3.5 for family support pre-diagnosis, and
4.1 at post-diagnosis. Using a standardized clinical tool to assess family support of newly
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diagnosed patients provides a common language for providers to discuss cases. In
addition, the assessment tool provided a tangible way to quantify data and to measure
progress (Davey et. al, 2009).
Lam, Naar-King, and Wright (2007) conducted a study to describe mental health
symptoms in HIV positive youth and to evaluate social support, disclosure, and health
status as predictors of symptoms including but not limited to: mood disturbance, anxiety,
social problems, suicidal ideation/attempts, and feelings of hopelessness. The sample
included 66 HIV positive youth between the ages of 16 and 25. Participants were
recruited from an adolescent HIV clinic within a children's hospital located in a major
metropolitan area.
Results of this study identified lower social support, higher viral load, HIV-status
disclosure to acquaintances, and being gay/lesbian/bisexual (GLB) were all significantly
correlated to more mental health symptoms. The percentage of participants with
behaviorally acquired HIV, perinatally acquired HIV, or transmission through sexual
assault was not distinguished. The way in which HIV was acquired, may largely impact
the presence of mental health symptoms in the individual (Lam, Naar-King, & NaarWright, 2007).
Murphy et al. (2000) designed a study to investigate the effects of life events,
social support, and coping on anxiety and depression with HIV positive adolescents.
Adolescents who were infected through sexual behavior or injective drug use behaviors
and were currently receiving primary care were eligible for the study. Participants
included 230 adolescents from 16 different cities nationwide. The researchers
hypothesized that an increase in stressful life events would be correlated to higher levels
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of anxiety and depression, but this association would be regulated with satisfaction with
social support and by practicing adaptive coping. The results of this study indicated that
although life event distress was directly associated with psychological distress, neither
social support nor adaptive coping seemed to moderate this association (Murphy et al.,
2000).
This study did not account for adolescents with perinatal HIV infection. In
addition, it excluded a large proportion adolescents with HIV living in rural areas, as
well as those adolescents that are not connected to services. In addition, this study did not
consider how differences in race, ethnicity, or socio-economic status may impact social
support. Nor did it consider that there may be varying configurations of social support.
Stages of development indicate that adolescents’ social support networks are primarily
composed of their peers. This aspect was not assessed in the study.
Similarly Battles and Weiner (2002) designed a descriptive, longitudinal study to
examine the psychosocial factors associated with long-term survival of pediatric HIV.
Children enrolled in clinical trials in the Pediatric HIV Working Group of the HIV/AIDS
malignancy branch of the National Cancer Institute, along with one of their primary
caregivers. Children were administered three separate scales and participated in a semistructured interview, and their caregivers completed two separate measures. Study
measures were administered every 12 months over a period of three years. The results of
this study indicated that the transition from adolescence to young adulthood is “not an
easy one” as living with “a potentially life-threatening and stigmatizing disease leads to
psychological distress as the adolescent enters adulthood.” However social support and
disclosure can alleviate some of these affects. Findings specifically demonstrate that there
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is a direct correlation between perceived social support and parent-reported problem
behavior (Battles & Weiner, 2002).
The sample used in this study is not ethnically or racially representative of
pediatric HIV patients living in the United States. In addition, the patient cohort in this
study over-presents resourceful families that were able to participate in clinical trials.
These families may not face additional life stressors including poverty, violence, and
substance use.
At the beginning of the epidemic, HIV infected children were often socially
ostracized and attempts were made to prevent them from attending their schools. Because
“HIV may adversely affect a child’s neurodevelopment, they are more likely to require
special services than uninfected children.” Frequent medical appointments or
hospitalizations will result in multiple school absences. Erin Mialky, James Vagnoni, and
Richard Rutstein (2001) designed a study to explore the medical, educational, and
psychosocial issues that develop among school-aged children living with perinatally
acquired HIV. The sample included 54 children and their caregivers who were
interviewed about the student’s educational setting, utilization of special services, school
performance, number of school absences, medications, absences, activities, and
disclosure status.
The data collected in this study yielded that children generally adapted well to
taking their medication in a school setting. In addition, the results indicated that HIVinfected children have an increased need for special educational services. However, the
study team asserted that it is impossible to determine whether the need for additional
services can be attributed to HIV infection, drug therapy, or other environmental factors.
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In addition, the results of the study are not representative of the entire population of
school-aged children with perinatally acquired HIV (Mialky, Vagnoni, & Rutstein, 2001).
Current literature adequately addresses the ways in which family support is
directly correlated to physical health and emotional wellbeing of children and young
adults living with HIV infection. However, researchers have not considered the makeup
of the family unit itself. This study will consider the definition of family through the
unique lens of adolescents with perinatal HIV infection.
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CHAPTER III
METHODOLOGY
This qualitative study was designed to determine how youth living with
perinatally-acquired HIV define family, and whether or not their family members help or
hinder their ability to cope with a lifelong illness. Conducting in-depth interviews
allowed this researcher to obtain more information about each participant’s unique
experience. Conducting a face-to-face interview is more personal, and provides the
participant with an opportunity to share their narrative. This chapter identifies the
methods employed in this study and describes the sample selection, data collection, and
data analysis procedures.
Sample
Study participants were limited to patients ages 18 to 24 with perinatally-acquired
HIV infection currently being followed in the Intensive Primary Care Clinic (IPC) at
Johns Hopkins Hospital for comprehensive HIV primary care. Patients with significant
cognitive developmental delay or serious mental illness, which would preclude safe or
meaningful participation in the study interview, were excluded.
The participants for this qualitative study were recruited via a convenience
sampling method. The research team created a list of eligible participants by using the
clinic roster to identify all IPC patients with perinatally-acquired HIV infection who are
18 years or older. This list was reviewed with the primary care team at the weekly IPC
clinical team meeting to remove any patients with serious cognitive developmental delay
or serious mental illness. The first 12 eligible participants who came to clinic for a
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routine visit, were approached about participating in the study by a member of the IPC
team. This researcher then met with interested patients in a private clinic room to discuss
the study and obtain written informed consent.
Data Collection
Data collection was gathered via semi-structured interviews conducted in the
outpatient medical clinic. Each participant participated in one interview. The interviews
were composed of a series of open-ended questions as outlined in the interview guide
(see Appendix C). Prior to beginning data collection, procedures to protect the rights and
privacy of participants were outlined and submitted to the Institutional Review Board
(IRB) at Johns Hopkins Medical Institution for approval (see Appendix A). Each
participant was given a copy of the informed consent form, which described their
participation in the research study as well as their rights as human subjects (see Appendix
B). The researcher carefully reviewed each section of the consent form with the
participant and allowed time for questions and clarification. The researcher and
participant each kept a copy of the signed document. The researcher will keep the signed
consent forms in a secure environment separate from the data for three years after the
conclusion of the study as mandated by Federal regulations.
Each interview was digitally recorded to ensure accuracy of responses. The
interviews were transcribed by a professional transcription service. Any names or other
identifiable information from participants gathered during the interviews were
subsequently removed during the transcription process for privacy purposes. The
recordings will subsequently be destroyed in concordance with HIPAA guidelines.
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After obtaining the signed consent form, the researcher asked each participant five
questions in sequential order. The interview questions were intended to elicit the ideas,
opinions, and experiences of the participant. At times, the researcher clarified questions
or offered probing questions to obtain additional information regarding the topic. Each
interview was digitally recorded. The entire interview process, including obtaining
consent and debriefing, ranged in length from 30 to 45 minutes. Participants were
compensated with $25.00 in cash for their time and travel expenses. All interviews took
place from March through April 29, 2010.
Data Analysis
Data collected during the taped interviews were transcribed and then analyzed for
thematic content. The researcher then coded the data. First, the transcripts were sorted by
questions, and then into smaller categories based on similar words and phrases offered by
the study participants.
As a Caucasian female researcher in her mid-twenties, I considered how my
identity and personal experiences impacted the interview process. I recognized that each
participant answered the interview questions from their unique lens. In addition, I was
cognizant of rapport with each participant. I was cautious of how my personal biases or
preconceptions could potentially influence responses or interpretations of responses. It
was also imperative that they did not feel coerced into participating in the study given
that the researcher was also a staff member and in a position of authority. It was also
necessary that the participants understand that the care they receive at the IPC clinic was
not going to be impacted by their decision to participate in the study.
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All interviews were conducted during regular clinic hours when the primary care
team was present on site. The IPC social worker or another member of the primary care
team was available in the event that a participant voices distress during or after the
interview process. IPC patients with known mental health conditions that might put them
at risk for heightened distress were excluded from participation. The questions and
content of the interviews are part of the standard psychosocial history collected during
routine clinical visits. Some participants may have felt sad or angry while discussing their
families or their HIV status; however, there was no greater risk of causing emotional
distress in the context of the research interview.
This study offered participants an opportunity to share their personal stories.
Knowing that the research team is interested in improving care by learning more about
living with a lifelong illness may increase rapport with the patient. Requesting to hear
their unique stories and recognizing their level of resiliency, validates that they have
confronted enormous obstacles throughout their lifetimes.
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CHAPTER IV
FINDINGS
The purpose of this study was to explore how youth living with perinatally
acquired HIV describe the composition of their families, and whether their families (as
defined by the participant) have helped or hindered their ability to cope with their illness.
The sample was drawn from adolescents and young adults currently receiving primary
care from the Johns Hopkins Intensive Primary Care Clinic (IPC) located in Baltimore,
Maryland. The IPC clinic provides comprehensive medical care and psychosocial support
for over 200 children and youth from birth to 24 years. The majority of the patients come
from low socio-economic ethnic minority communities. All patients in the clinic were
English speaking. The sample included 12 perinatally HIV-infected adolescents, ranging
in age from 18 to 24. Three fourths of the participants were female. All participants self
identified as African American.
Participant Responses:
The first question posed in the interviews was aimed to elicit the images, phrases,
or descriptions that each participant associated with the word family.
1. What does the word family mean to you?
Five out of 12 participants stated that they associate family with the word “love.”
One third of the participants described families as a group of people that offers “support
and protection.” One fourth of the participants expressed that families are a “source of
comfort.”
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One participant envisioned her family as a group of individuals that: “tell you,
‘everything is going to be alright,’ or ‘you have nothing to worry about because I am here
for you.’ They just hold you if you are about to cry or they will take you in their arms and
talk to you.”
The following questions were intended to ascertain whether the participants had
families, who they considered to be a part of them, and how they became members of
their family. For purposes of consistent, accurate reporting, family constellations were
classified as the following: biological, chosen, adoptive, and family by marriage.
2. Do you have a family? Who makes up your family? How did they become
members of your family?
Eleven out of the twelve participants reported that they lost one or more of their
biological parents to AIDS. Three of the participants were placed in foster homes during
infancy and were later adopted. Three-fourths of the participants indicated that extended
family members raised them. Two participants indicated that they were raised by
extended family members, and then later transitioned into group home settings. One third
of the participants defined some of their family members as “chosen.”
Biological Family
This excerpt was extracted from the narrative of a participant who was raised by
her extended family following the death of her mother:
“My mother died when I was three. And my father I think died when I was two—
one or two. And they both had the virus. My uncle died in ’06, and he had the
virus. And other members of my family, they had the virus too … My
grandmother has had me ever since I was two days old … My family is mainly
my grandmother.”

22

Experience in Foster Care
The following quote was from a participant who spoke vividly about
her experience in one foster care home prior to being adopted at age ten:
“I can remember bits and pieces from the house I was placed in before. Her name
was _____. And she had me and this other boy, ______, my foster brother. But
she sent me back and kept him. She would keep us in this room, and there was no
bed, just a mattress on the floor. And we could only eat oodles of noodles. We
couldn’t go in her refrigerator, she would beat us if we even went into the
kitchen.”
Adopted Family
The following passage was drawn from the narrative of a participant who was
adopted in infancy:
“I never met my dad … well I met him at his funeral. I guess that doesn’t really
make sense, but that is how I met him … I would go to visit my [biological] mom
with my foster mother when I was younger, and we would spend time together—
so I was close to her. And then she died of AIDS. I knew my real parents, but this
is my real family because I’ve been there since I was two months old … My
[adopted] mom, she treats me like I’m one of her own children, not different from
her real kids.”
Chosen Family
The following passage was taken from the account of a participant who defines
her family as chosen.
“So my biological mother, she’s deceased. She couldn’t take care of me. She was
schizophrenic. I was placed into department of social services care. I went into a
foster home. I had five other [foster] siblings there. [My foster mom] adopted all
five. She didn’t adopt me … I moved out and basically ever since I’ve been in
group homes and foster homes. I wouldn’t say I have my own personal family. I
don’t know what the word “family” is … When it comes to my son, that’s my
family … My son’s godmother, I consider her my sister and I’ve only known her
for a year … A lot of my friends I consider family [members]."
In response to how individuals become members of her chosen family, one
participant stated: "By helping me deal with my hardships … or they just happened to
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have been close to me because I was able to tell them about my virus, and about my
family, and what I go through. That's how they will become a part of my family."
The third question was intended to clarify whether the participants’ perceptions of
their families have changed over the course of their lifetime.
3. How has your family changed over time?
None of the participants alluded to major changes in their families. All of the
responses indicated that changes included normal fluctuations in size due to births,
deaths, or family discord. Despite experiencing multiple losses and shifts in family
structure due to HIV/AIDS, none of the participants discussed whether their perceptions
of families or their roles had changed over the course of their lifetime. In addition, none
of the participants relayed that they lost or became estranged from their family members
because of their positive HIV status. One participant commented on her family dynamic:
“We all grew up. We all got older. I mean, there are times when there’s points in
everybody’s life when they feel like they don’t want to be bothered or they get
agitated fast. Everybody goes through that. But their personalities haven’t
changed. They’re always still the loving, caring people that I know."
The fourth set of questions posed during the interview was intended to elicit
whether families (as defined by the study participants) helped or hindered their ability to
cope with their illness.
4. How have family members helped or hurt the process of managing your
illness? How has your family supported you? In what ways have they made it difficult for
you?
All of the study participants reported that their family members support them by
reminding them to take their medication. Referring to a chosen family member, one
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participant relayed, “She always reminds me to take my medicine. She calls me. She
gives me reminders. She sends me alarm clocks and calendars and everything else to
remind me.” One third of the participants indicated that their family members also offer
support by providing transportation to and from doctor’s appointments and the pharmacy.
One third of the participants asserted that their families support them by checking in on
them to see if they are doing ok. One participant mentioned that her family provides
emotional support regarding her positive HIV status. The following passage illustrates
one participant’s experience with her adopted family:
“They don’t remind me that I have it. They treat me like I’m a regular person.
They don’t second-guess anything, like when I’m eating my food and I don’t want
anymore. They’re like, ‘Can I have it?’ They’ll still eat it and all that stuff and
they don’t let the stereotypes about HIV get to them. They stay eating my stuff
and they stay drinking my stuff … They just help me stay grounded. They help
me realize I’m still a regular person. I can do everything everybody else is doing.”
Notably, only two participants expressed anger towards their biological mothers
for giving them HIV. Only one participant reported that her family makes it difficult for
her to cope with her illness. The other 11 participants relayed that their families have not
directly or intentionally hindered their ability to cope with HIV; however, they recounted
issues and specific incidents that impacted them. The following quotations are a
compilation of some of the factors that contributed to their struggle:
“My mother, she’s a real supportive person. And sometimes I get emotional and
depressed about my condition, and she tries to help me and tries to talk to me
about it. But it don’t really work because she is not in my position.”
“She would literally make me take my medicine. She would put it in my mouth
and make me swallow it or she was going to beat me. So either I was going to
take it or I was going to get beaten and still have to take it. So I’d just take it and
go in the bathroom and throw it up. I thought, ‘I don’t want to take this crap, I’m
not sick.’”
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One participant who was adopted by a family, shared her experience of feeling
like an “outsider:”
“I didn’t know that they weren’t my biological family until middle school … If
you look at my family, they’re more darker than me, so, I’m the lightest one in the
family if you took a family photo. And so I wondered, why am I the lightest one
in the family?”
One young woman relayed that her family members did not know that about her
positive HIV status until she was twenty years old. She recounted that her mother made
the decision not to tell anyone until she was on her death bed:
“When she was in the hospital she told them [family] ... When went to the
hospital, my grandma told us she was gone. She died after she told them about me
… After that I went into the room to calm my sister done because she was crying
… Then my brother came in, and we all put make-up on her and combed her
hair.”
It is notable that all participants identified being reminded to take their medication
as the primary manner in which their family members provide support. Because adhering
to the anti-retroviral treatment regimen directly impacts viral load and CD4 count, the
family members' efforts to remind them to take their medication implies concern for their
physical health and wellbeing. Rather than identify emotional support, for example, as
the primary source of support, the participants listed functional, practical needs such as:
daily reminders to take their medication or transportation to and from their doctor's
appointments.
Given that all participants have been aware of their positive status for at least 10
years, their responses may imply that they are more adjusted to having a chronic illness.
This common response may also be explained by considering the appropriate stage of
development. During adolescence, individuals tend to rely more heavily on their peers for
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emotional support rather than their family members. Managing a chronic illness in
addition to navigating identity formation may imply the need for additional support.
Another theme that emerged was that three fourths of the participants recounted
when they learned of their illness. Although this researcher did not directly ask about the
topic of disclosure, many of the participants vividly described when they were informed
that they were HIV positive. One participant recalled that he learned that he had HIV
when he was 10 years old: “Before I went to bed one night, I peed on the toilet seat by
accident. My aunt told me what I got and how I got it—she told me I couldn’t be doing
that anymore. I was shocked.” One young woman reported that she learned of her HIV
status when she was six years old: “I started getting fevers. I didn’t know what was
wrong with me. I started getting very, very sick. So my aunt took me to the doctors and
they told me I had HIV.” Another participant recalled, “My [foster] mom told me and she
explained what was going on and I felt as though there was a connection because
everybody was so concerned, everybody asked me if I was ok.”
The participants were told about their HIV status in different ways and at different
stages of their development. Another participant described how she confronted her
mother after discovering that she had HIV when she was 12 years old:
“Mom, you didn’t have enough sense to not share a needle with somebody that
you knew had it. She knew the guy had HIV or AIDS and she was sharing a
needle with him while she was pregnant with me. You should know better not to
use drugs while you’re pregnant. She said she caught it from him and didn’t find
out until she was eight months pregnant. They keep telling me I can’t blame her.
Yes, I can. I can blame her because she knew about it … My little sister don’t got
it. Why it got to be me?”
The data collected indicated that the context of disclosure and availability of
support impacted the way in which the participant understood their illness. One
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participant relayed that her [foster] mother explained her illness on three separate
occasions: at age 7, age 12, and again at age 15. She asserted that at age 15, "she really
broke it down to me. She pulled a whole thing up on the internet and had books, and
when she talked about it she had stacks of paper about this high … And I told her, 'no,
that's not going to happen, I'm going to die. I'm going to die.'" The participant later
acknowledged that although her mother read "a bunch of medical stuff, she really didn't
understand it [HIV] herself as much as she wanted to … but she always wants me to do
the right thing and take my medicine."
Conclusion
The findings of this study indicate that all participants recognize a specific group
of individuals as members of their family; however, the way in which these individuals
became family members varies greatly. Not surprisingly, 11 out of the 12 participants
mentioned that they had lost one or both parents to the AIDS virus. As a result, they
survive by a composition of extended family, foster, adoptive, and chosen family
members. Clinicians must consider these unique family constellations when devising
treatment plans and assisting these individuals with managing a lifelong illness.
Study Strengths and Limitations
The results of this qualitative study are not representative of the entire population
of young adults living with perinatal HIV infection. Factors that impact generalizability
include: small sample size and use of a convenience sampling procedure. Other
limitations include a lack of diversity among the following descriptive categories: race,
ethnicity, socioeconomic status, gender, and geographic location.
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In addition, the reader must consider the cultural bias of the researcher, a
Caucasian female in her mid-twenties. Personal biases and preconceptions could have
influenced responses or interpretations of responses. However, these narratives provide
insight into the experiences of young adults living with perinatally acquired HIV—a
population that few researchers have explored. The following chapter will compare and
contrast these findings to previous research.
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CHAPTER V
DISCUSSION
The purpose of this qualitative study was to explore how young adults with
perinatal HIV infection understand and experience the concept of family and to elicit
their perceptions of how “family” has helped or hindered their ability to cope with their
illness. Researchers published an extensive amount of literature pertaining to individuals
with HIV/AIDS. However, there are few studies that examine the lives and experiences
of young adults with perinatal HIV infection. The lack of literature is largely due to the
fact that children born with HIV during the first two decades of the pandemic were not
expected to live beyond childhood. Because of advances in anti-retroviral treatment, an
increase in prevention efforts, and knowledge of disease progression, the morbidity rates
of HIV infection have dramatically decreased in the United States. Therefore, medical
providers are currently witnessing the first wave of adolescents with perinatally acquired
HIV disease transition into adulthood.
Family Constellations
The data collected offered tremendous insight regarding how the participants
define family. Eleven out of the 12 participants lost one or both biological parents to
HIV/AIDS. These results are consistent with the statistics completed by the CDC, which
reported that an estimated 80,000 children and adolescents were orphaned since the
beginning of the AIDS pandemic. Due to the loss of their primary caregiver(s) during
infancy or early childhood, participants conveyed that they were raised by extended
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family members, placed in foster care or group home settings, or were adopted.
Surprisingly, only four of the participants referred to some of their family members as
chosen. Perhaps this can be attributed to society’s perception of a family, consisting of
two parents and children. The need to have a “normal” family or one that fits into
society’s construction of a family, may explain why the participants often did not
differentiate between biological, foster, and adoptive parents in their narratives.
Medication Adherence
All participants stated that their family members provide support by reminding
them to take their medication. However, not all participants clarified whether they were
consistently adhering to the medication regimen. Nor did they indicate whether they were
more likely to take their medication if they were reminded. Previous research suggests
that youth with perinatal HIV infection may stop adhering to their treatment regimen
during adolescence for a number of different reasons (Ledlie, 2001). Therefore, stating
that they receive consistent reminders to take medication implies that the participants
consider the reminders as concern for their physical health and well-being.
Disclosure
Although this researcher did not directly ask study participants about when they
first learned of their illness, many included this important event in their narratives.
The participants were told about their HIV status in different ways and at different stages
of their development. This information confirms previous research relating to the
importance of disclosing in a developmentally appropriate manner. The inclusion of the
disclosure process without being prompted, confirms that it was a significant life event.
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Areas of further research
This large cohort of young adults with perinatal HIV infection is the first, and
perhaps the last, due to prevention of HIV transmission from mother to child with
advancements in treatment regimens. Therefore, there are multiple topics not adequately
addressed in the current literature. Researchers may consider interviewing the foster and
adoptive parents, as well as extended family members, that raised these children from
infancy. Compiling feedback and gaining insight regarding their experiences may be
useful in designing future programs offering support to families with a child with a
chronic illness. It would also be beneficial to further explore the ways in which clinicians
can facilitate a successful transition for individuals born with HIV from pediatric to adult
care. In addition, research that investigates how young adults of different ethnic, cultural,
and religious backgrounds cope with chronic or terminal illness would be helpful.
Considering individual differences is essential to establishing rapport with patients and to
develop appropriate treatment plans to meet their needs.
Implications for the field of Social Work
When working with children or young adults with HIV infection, clinicians
should be mindful of how patients cope with their illness and whom they look to for
support. Clinicians working with this population may provide the following services:
counseling for patients and their family members, support with the adjustment to a highly
stigmatized, lifelong illness, risk reduction, assistance with medication adherence and
disclosure of positive status to peers, and mobilization of resources. Now, more than
ever, clinicians need to take an active role in helping these young adults prepare for the
future and independent living.
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Conclusion
This research study provided insight into the distinctive life experiences of young
adults living with perinatal HIV infection. As they navigate the transition into adulthood
with a chronic illness, clinicians have the responsibility to provide support and resources
to them and their families. Because this is a new phenomenon, further exploration of the
obstacles that this population may be confronted with is necessary.
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APPENDIX B: INFORMED CONSENT FORM
Approved February 22, 2010
Date: January 22, 2010 Principal Investigator: Dr. Nancy Hutton Application No.: NA_00034532
Patient I.D. Plate

RESEARCH PARTICIPANT INFORMED CONSENT
AND PRIVACY AUTHORIZATION FORM
Protocol Title:"Who's my family?" A qualitative study of young adults
living with perinatal HIV infection
Application No.: NA_00034532 Principal Investigator: Dr. Nancy Hutton
1.

What you should know about this study:

•
•
•
•
•

You are being asked to join a research study.
This consent form explains the research study and your part in the study.
Please read it carefully and take as much time as you need.
Please ask questions at any time about anything you do not understand.
You are a volunteer. If you join the study, you can change your mind later. You can
decide not to take part or you can quit at any time. There will be no penalty or loss
of benefits if you decide to quit the study.
During the study, we will tell you if we learn any new information that might affect
whether you wish to continue to be in the study.
Ask your study doctor or the study team to explain any words or information in this
informed consent that you do not understand.

•
•

2.

Why is this research being done?
This research is being done to understand who makes up your family, and whether
they help or do not help you with your illness.
Patients of the Intensive Primary Care Clinic who were born with HIV and are now
18 years of age and older may join this study.
How many people will be in this study?
About 12 to 15 people will be in this study.

3.

What will happen if you join this study?

•
•
•

If you agree to be in this study, we will ask you to do the following things:
Participate in one interview.
The interview will last about 30 to 45 minutes.
Your answers to the questions will be recorded on the computer, so that I will not
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have to take so many notes while we are talking. The recording will then be
transcribed and destroyed.
How long will you be in the study?
You will be in this study for one interview.

4.

What are the risks or discomforts of the study?

•

•

If you feel uncomfortable or upset when I am asking you questions during the
interview, please ask me to stop and I will get a social worker to help.
You may get tired or bored when we are asking you questions or you are
completing questionnaires.
You do not have to answer any question you do not want to answer.

5.

Are there benefits to being in the study?

•

There is no direct benefit to you for being in this study. If you take part in this
study, you may help others in the future.

6.

What are your options if you do not want to be in the study?
You do not have to join this study. If you do not join, your care at Johns Hopkins
will not be affected.

7.

Will it cost you anything to be in this study?
No

8.

Will you be paid if you join this study?
You will be given $25.00 cash at the end of the interview for your time and local
travel to and from the clinic.

9.

Can you leave the study early?

•
•
•

You can agree to be in the study now and change your mind later.
If you wish to stop, please tell us right away.
Leaving this study early will not stop you from getting regular medical care.

10. How will your privacy be protected?
Johns Hopkins has rules to protect information about you. Federal and state laws
also protect your privacy. This part of the consent form tells you what information
about you may be collected in this study and who might see or use it.
Generally, only people on the research team will know that you are in the research
study and will see your information. However, there are a few exceptions that are
listed later in this section of the consent form.
The people working on the study will collect information about you. This includes
things learned from the procedures described in this consent form. They may
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collect other information including your name, address, date of birth, and other
details.
The research team will need to see your information. Sometimes other people at
Johns Hopkins may see or give out your information. These include people who
review the research studies, their staff, lawyers, or other Johns Hopkins staff.
People outside of Johns Hopkins may need to see your information for this study.
Examples include government groups (such as the Food and Drug Administration),
safety monitors, other hospitals in the study and companies that sponsor the study.
We cannot do this study without your permission to use and give out your
information. You do not have to give us this permission. If you do not, then you
may not join this study. We will use and disclose your information only as
described in this form and in our Notice of Privacy Practices; however, people
outside Hopkins who receive your information may not be covered by this promise.
We try to make sure that everyone who needs to see your information keeps it
confidential – but we cannot guarantee this.
The use and disclosure of your information has no time limit. You can cancel your
permission to use and disclose your information at any time by calling the Johns
Hopkins Privacy Officer at 410-735-6509 or by sending a letter to:
Johns Hopkins Privacy Officer
5801 Smith Avenue McAuley Hall, Suite 310
Baltimore, MD 21209
Fax: 410 735-6521
Please be sure to include the name of the principal investigator, the study number
and your contact information. If you do cancel your permission to use and disclose
your information, your part in this study will end and no further information about
you will be collected. Your cancellation would not affect information already
collected in this study.

11. Will the study require any of your other health care providers to
share your health information with the researchers of this study?
As a part of this study, the researchers may ask to see your health care records from
your other health care providers. We will ask these other health care providers to
give us information about your health status including your T-cell count and viral
load.

12. What other things should you know about this research study?
a.

What is the Institutional Review Board (IRB) and how does it protect you?
The Johns Hopkins Medicine IRB is made up of:
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•
•
•
•
•

Doctors
Nurses
Ethicists
Non-scientists
and people from the local community.
The IRB reviews human research studies. It protects the rights and welfare of the
people taking part in those studies. You may contact the IRB if you have questions
about your rights as a participant or if you think you have not been treated fairly.
The IRB office number is 410-955-3008. You may also call this number for other
questions, concerns or complaints about the research.

b.

What do you do if you have questions about the study?
Call the principal investigator, Dr. Nancy Hutton at 410-614-5961. If you cannot
reach the principal investigator or wish to talk to someone else, call the IRB office
at 410-955-3008.

c.

What happens to Data, Tissue, Blood and Specimens that are collected in the
study?
Scientists at Johns Hopkins work to find the causes and cures of disease. The data
collected from you during this study are important to both this study and to future
research.
If you join this study:

•
•
•
•
•

You will not own the data given by you to the investigators for this research.
Both Johns Hopkins and any sponsor of this research may study your data collected
from you.
If data are in a form that identifies you, Johns Hopkins may use them for future
research only with your consent or IRB approval.
You will not own any product or idea created by the researchers working on this
study.
You will not receive any financial benefit from the creation, use or sale of such a
product or idea.

d.

What are the Organizations that are part of Johns Hopkins?
Johns Hopkins includes the following:

•
•
•
•
•

The Johns Hopkins University
The Johns Hopkins Hospital
Johns Hopkins Bayview Medical Center
Howard County General Hospital
Johns Hopkins Community Physician
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13. What does your signature on this consent form mean?
Your signature on this form means that:
•
•
•

You will not give up any legal rights by signing this consent form.
You understand the information given to you in this form.
You accept the provisions in the form you agree to join the study

WE WILL GIVE YOU A COPY OF THIS SIGNED AND DATED
CONSENT FORM
___________________________________________________________________________________________________________________

Signature of Participant

Date

__________________________________________________________________________________
Signature of Person Obtaining Consent Date
NOTE: A COPY OF THE SIGNED, DATED CONSENT FORM MUST BE KEPT BY THE
PRINCIPAL INVESTIGATOR; A COPY MUST BE GIVEN TO THE PARTICIPANT; AND,
IF APPROPRIATE A COPY OF THE CONSENT FORM MUST BE PLACED IN THE
PARTICIPANT‘S MEDICAL RECORD.
Combined Informed Consent/Authorization January 2010 Version 11
Page 5 of 5

40

APPENDIX C: INTERVIEW GUIDE
Interview Guide:
1. What does the word “family” mean to you?
2. Do you have a family? Who makes up your family? How did they become members
of your family?
3. Have the members of your family changed over the course of your lifetime?
4. How have family members helped or hurt the process of managing your illness? How
has your family supported you? In what ways have they made it difficult for you?
5. If I have questions later about this interview, how may I contact you?
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